SF3B1K700E重新连接细胞循环调节器的拼接
Mai Baker1, Eden Engel2, Aveksha Sharma2
1Al-Quds University.
概括
在SF3B1 (一个spliceosome组件) 中的突变破坏RNA拼接,影响细胞周期控制和促进癌症. SF3B1K700E突变特别改变了ARPP19等G2/M调节者的拼接,影响了细胞分裂和患者存活率.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 遗传学 遗传学 是一个
背景情况:
- 预mRNA剪接对于细胞平衡至关重要,并且受到严格调节,特别是在细胞周期进展中.
- 拼接体组件SF3B1对于替代拼接至关重要,并且在癌症中经常发生突变.
- SF3B1K700E突变破坏了拼接和细胞周期控制,导致瘤发生.
研究的目的:
- 研究SF3B1K700E突变对RNA拼接模式的影响.
- 为了确定与SF3B1K700E突变相关的拼接变化及其功能后果.
- 探索SF3B1依赖拼接,细胞循环调节和癌症发展之间的关系.
主要方法:
- 对表达野生型或SF3B1K700E.的K562红血球白血病细胞进行RNA测序 (RNA-seq).
- 在HeLa细胞中通过siRNA介导的SF3B1的耗尽,以验证依赖突变的拼接特征.
- 药理上抑制DYRK1A和氨酸/氨酸酸酶.
- 功能性检测包括ARPP19长异型的异位表达.
- 对TCGA-AML队列数据的分析.
主要成果:
- 在对G2/M调节器 (例如ARPP19,ENSA,STAG2,ECT2) 进行丰富的SF3B1K700E细胞中确定了763个高置信度拼接变化.
- 增加ARPP19外因子2的纳入导致ARPP19长异型,抑制PP2A-B55并促进线粒分裂.
- 在SF3B1枯竭后观察到一组与SF3B1K700E相关的拼接变化,这表明了突变特异的拼接酶体特征.
- 激酶-酸酶信号传递 (DYRK1A,酸酶) 影响ARPP19的外显子2的包含.
- 宫外ARPP19-long表达加速了线粒体的退出;高的ARPP19-long水平与AML患者的存活率较差相关.
结论:
- SF3B1K700E突变驱动特定的剪接变化,影响细胞循环调节器.
- 长长的ARPP19异型在线索性进展中发挥作用,并且与AML的不良结果有关.
- 依赖SF3B1的拼接失调是癌症发展的关键机制,提供潜在的治疗点.
相关概念视频
Restarting Stalled Replication Forks
6.2K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.2K
The Cell Cycle Control System
5.2K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.2K
The Cell Cycle Control System
13.8K
The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
13.8K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Methods of Nuclear Reprogramming
2.1K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.1K


